These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34311462)

  • 1. RAP1GAP Functions as a Tumor Suppressor Gene and Is Regulated by DNA Methylation in Differentiated Thyroid Cancer.
    Faam B; Ghaffari MA; Khorsandi L; Ghadiri AA; Totonchi M; Amouzegar A; Fanaei SA; Azizi F; Shahbazian HB; Hashemi Tabar M
    Cytogenet Genome Res; 2021; 161(5):227-235. PubMed ID: 34311462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG Island Methylation of the Rap1Gap Gene in Medullary Thyroid Cancer.
    Faam B; Ghadiri AA; Ghaffari MA; Totonchi M; Amouzegar A; Azizi F; Shahbazian H; Hashemitabar M; Fanaei SA; Khorsandi L
    Arch Iran Med; 2022 Mar; 25(3):171-177. PubMed ID: 35429959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors upregulate Rap1GAP and inhibit Rap activity in thyroid tumor cells.
    Dong X; Korch C; Meinkoth JL
    Endocr Relat Cancer; 2011 Jun; 18(3):301-10. PubMed ID: 21367844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
    Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
    Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Rap1GAP through epigenetic silencing and loss of heterozygosity promotes invasion and progression of thyroid tumors.
    Zuo H; Gandhi M; Edreira MM; Hochbaum D; Nimgaonkar VL; Zhang P; Dipaola J; Evdokimova V; Altschuler DL; Nikiforov YE
    Cancer Res; 2010 Feb; 70(4):1389-97. PubMed ID: 20124489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas.
    Kondo T; Nakazawa T; Ma D; Niu D; Mochizuki K; Kawasaki T; Nakamura N; Yamane T; Kobayashi M; Katoh R
    Lab Invest; 2009 Jul; 89(7):791-9. PubMed ID: 19506552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HORMAD2 methylation-mediated epigenetic regulation of gene expression in thyroid cancer.
    Lin Q; Hou S; Guan F; Lin C
    J Cell Mol Med; 2018 Oct; 22(10):4640-4652. PubMed ID: 30039914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preserved SCN4B expression is an independent indicator of favorable recurrence-free survival in classical papillary thyroid cancer.
    Gong Y; Yang J; Wu W; Liu F; Su A; Li Z; Zhu J; Wei T
    PLoS One; 2018; 13(5):e0197007. PubMed ID: 29723302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation profiling of well-differentiated thyroid cancer uncovers markers of recurrence free survival.
    Mancikova V; Buj R; Castelblanco E; Inglada-Pérez L; Diez A; de Cubas AA; Curras-Freixes M; Maravall FX; Mauricio D; Matias-Guiu X; Puig-Domingo M; Capel I; Bella MR; Lerma E; Castella E; Reverter JL; Peinado MÁ; Jorda M; Robledo M
    Int J Cancer; 2014 Aug; 135(3):598-610. PubMed ID: 24382797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
    Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
    JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis.
    Hammad MO; Elabbasy LM; Abd Elghaffar MA; Zaki MMA; Bazeed FB; Zahran MA
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e154-e161. PubMed ID: 30884127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RAP1GAP inhibits cytoskeletal remodeling and motility in thyroid cancer cells.
    Dong X; Tang W; Stopenski S; Brose MS; Korch C; Meinkoth JL
    Endocr Relat Cancer; 2012 Aug; 19(4):575-88. PubMed ID: 22696507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Rap1GAP Expression Activates the TGF-
    Yan Z; Yangyanqiu W; Shuwen H; Jing M; Haihong L; Gong C; Yin J; Qing Z; Weili G
    Biomed Res Int; 2021; 2021():6840642. PubMed ID: 34840979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.
    Arturi F; Russo D; Bidart JM; Scarpelli D; Schlumberger M; Filetti S
    Eur J Endocrinol; 2001 Aug; 145(2):129-35. PubMed ID: 11454507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors.
    Bisarro Dos Reis M; Barros-Filho MC; Marchi FA; Beltrami CM; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4089-4099. PubMed ID: 28938489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assessment of RASSF1A methylation as a putative molecular marker in papillary thyroid carcinoma.
    Kunstman JW; Korah R; Healy JM; Prasad M; Carling T
    Surgery; 2013 Dec; 154(6):1255-61; discussion 1261-2. PubMed ID: 24383114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.